Immatics NV (IMTX)
7.58
-0.22
(-2.82%)
USD |
NASDAQ |
Nov 21, 16:00
7.586
+0.01
(+0.08%)
After-Hours: 20:00
Immatics Total Assets (Quarterly): 644.71M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 644.71M |
June 30, 2024 | 672.05M |
March 31, 2024 | 705.31M |
December 31, 2023 | 563.72M |
September 30, 2023 | 463.04M |
June 30, 2023 | 445.77M |
March 31, 2023 | 412.72M |
December 31, 2022 | 437.35M |
September 30, 2022 | 348.23M |
June 30, 2022 | 384.72M |
Date | Value |
---|---|
March 31, 2022 | 314.95M |
December 31, 2021 | 197.74M |
September 30, 2021 | 230.72M |
June 30, 2021 | 257.65M |
March 31, 2021 | 278.74M |
December 31, 2020 | 313.20M |
September 30, 2020 | 332.30M |
June 30, 2020 | 121.39M |
December 31, 2019 | 150.41M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
121.39M
Minimum
Jun 2020
705.31M
Maximum
Mar 2024
382.88M
Average
348.23M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
Affimed NV | 44.63M |
InflaRx NV | 89.00M |
BioNTech SE | 25.02B |
CureVac NV | 954.04M |
ATAI Life Sciences NV | 197.52M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 217.47M |
Shareholders Equity (Quarterly) | 427.24M |
Current Ratio | 3.978 |